Patient Safety First!
How to Effectively Reduce Human Papillomavirus (HPV) Cross-Contamination Risk in Ultrasound Examinations
Fertility Conference Webinar
How to Effectively Reduce Human Papillomavirus (HPV) Cross-Contamination Risk in Ultrasound
Speakers: Dr Craig Meyers, World Renowned Expert in HPV Research, Professor of Microbiology and Immunology, Penn State College of Medicines & Dr David Weber, Professor of Medicine, Pediatrics, Epidemiology Associate Chief Medical Officer, UNC Hospitals Medical Director, Hospital Epidemiology
Host: Glen Ewing, Director, Germitec UK
Synopsis: Dr David Weber will provide a research overview on vaginal ultrasound probe contamination despite the use of probe covers and Low-Level Disinfection. Dr Craig Meyers will then give his expertise in HPV research. He was the first lab to develop a technique to grow natural High-Risk HPV that causes 90% of cervical cancer and other anogenital cancers. He will discuss how it has been applied in product research to ensure US probe reprocessing effectively kills the virus.
Q&A Discussion topics
What is the process for a manufacturer to have their medical device tested against HPV, and what is the time frame?
- “Need to contact the company directly to find out if the medical device has been HPV tested. As not all tests get published.”
- “We discuss with the company test protocols and controls when designing the HPV study. The test outcomes take about four weeks.”
What disinfection systems have been tested to be effective against HPV?
Hypernova Chronos is leading
the way in High Level Disinfection (HLD)
Hypernova Chronos is leading the way in High Level Disinfection (HLD) as the only automated system proven to kill native human papillomavirus (HPV) both in vitro and in clinical use.1,2
- Meyers J, Ryndock E, Conway MJ, Meyers C, Robison R. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother. 2014;69(6):1546-50.
- Meyers C, Milici J, Robison R (2017) UVC radiation as an effective disinfectant method to inactivate human papillomaviruses. PLoS ONE 12 (10): e0187377.
- Maxime Pichon, Karine LebailCarval, Geneviève Billaud, Bruno Lina, Pascal Gaucherand and Yahia Mekki (2019) Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System. J. Clin. Med, 8, 1776; doi:10.3390/jcm8111776.